Until Monday, "Cythera" was known more as a computer game than as the name of a biotechnology company.
But CyThera Inc, which has no connection to the computer game, is overshadowed no more. The company, which was not known to be working on human embryonic stem cells, turns out to have derived nine colonies of such cells, according to a list released by the National Institutes of Health on Monday. That is more than other organizations better known for stem cells, such as the University of Wisconsin -- and second only to Goteborg University in Sweden, which has 19, according to the NIH list of stem-cell lines that will be eligible for use by federally financed scientists.
That could mean that CyThera will be sought out by academic scientists who are anxious to begin work on cells that they think can be used to grow heart, brain, liver and other cells to repair damaged organs. But CyThera, based in San Diego, said it is not quite ready for the limelight. It is privately held, with only US$2 million in venture financing, and it has only 10 employees.
"We're sort of blushing brides here," said Michael J. Ross, the company's president and chief executive.
The company's goal is to grow insulin-producing pancreas cells that can be implanted in patients to treat diabetes. But until now the company has not publicized the fact that it is using embryonic stem cells in its research.
"When I saw on that list that they had all those stem-cell lines, I was surprised," said Susan Bonner-Weir, an expert on diabetes cell therapy at the Joslin Diabetes Center in Boston and Harvard Medical School.
Ross said CyThera kept quiet because there was "no advantage to publicity, especially in an area that some people consider controversial."
But when it became clear, he said, that the NIH was drawing up its list of laboratories with stem cells, the company realized it should get on the list so it would be able to share its cells with academic scientists in the future.
But CyThera executives said it will be months, maybe longer, before the company is ready to provide cells to researchers. The company, which is worried about being overwhelmed by requests for cells, said it first needs to better characterize the properties of the cells it has.
Ross said CyThera has so many cell lines because the company was trying to find a different way to derive stem cells from the method used at the University of Wisconsin, where the first human embryonic stem cells were isolated three years ago.
"We weren't just trying to derive cell lines," he said. "We were trying to derive cell lines that are independent, and improve the techniques."
Ross said CyThera's method differs from Wisconsin's not in the way cells are obtained -- from discarded embryos at fertility clinics -- but in the way the cells are cultured.
He said he thinks the cells might avoid infringing Wisconsin's stem-cell patent, though that is not clear. Commercial rights to develop pancreatic cells under the Wisconsin patent have been licensed to Geron Corp of Menlo Park, California.
Doctors in Edmonton, Alberta, last year showed great success in weaning about a dozen diabetics from insulin injections by using cells derived from cadavers. That means that when CyThera does have some cells ready for transplant, it will already know how many cells are needed and where best to transplant them, taking some of the risk out of the clinical trials. CyThera is now trying to raise an additional US$8 million. It will take tens of millions of dollars and several years to advance to early clinical trials, in which the company will try to prove that the concept can work.
There are other companies working on a variety of cell therapies for diabetes. These include Curis of Cambridge, Massachusetts; Theracyte Inc of Irvine, California; and Islet Sheet Medical LLC of San Francisco.
NO HUMAN ERROR: After the incident, the Coast Guard Administration said it would obtain uncrewed aerial vehicles and vessels to boost its detection capacity Authorities would improve border control to prevent unlawful entry into Taiwan’s waters and safeguard national security, the Mainland Affairs Council (MAC) said yesterday after a Chinese man reached the nation’s coast on an inflatable boat, saying he “defected to freedom.” The man was found on a rubber boat when he was about to set foot on Taiwan at the estuary of Houkeng River (後坑溪) near Taiping Borough (太平) in New Taipei City’s Linkou District (林口), authorities said. The Coast Guard Administration’s (CGA) northern branch said it received a report at 6:30am yesterday morning from the New Taipei City Fire Department about a
IN BEIJING’S FAVOR: A China Coast Guard spokesperson said that the Chinese maritime police would continue to carry out law enforcement activities in waters it claims The Philippines withdrew its coast guard vessel from a South China Sea shoal that has recently been at the center of tensions with Beijing. BRP Teresa Magbanua “was compelled to return to port” from Sabina Shoal (Xianbin Shoal, 仙濱暗沙) due to bad weather, depleted supplies and the need to evacuate personnel requiring medical care, the Philippine Coast Guard (PCG) spokesman Jay Tarriela said yesterday in a post on X. The Philippine vessel “will be in tiptop shape to resume her mission” after it has been resupplied and repaired, Philippine Executive Secretary Lucas Bersamin, who heads the nation’s maritime council, said
REGIONAL STABILITY: Taipei thanked the Biden administration for authorizing its 16th sale of military goods and services to uphold Taiwan’s defense and safety The US Department of State has approved the sale of US$228 million of military goods and services to Taiwan, the US Department of Defense said on Monday. The state department “made a determination approving a possible Foreign Military Sale” to the Taipei Economic and Cultural Representative Office in the US for “return, repair and reshipment of spare parts and related equipment,” the defense department’s Defense Security Cooperation Agency said in a news release. Taiwan had requested the purchase of items and services which include the “return, repair and reshipment of classified and unclassified spare parts for aircraft and related equipment; US Government
More than 500 people on Saturday marched in New York in support of Taiwan’s entry to the UN, significantly more people than previous years. The march, coinciding with the ongoing 79th session of the UN General Assembly, comes close on the heels of growing international discourse regarding the meaning of UN Resolution 2758. Resolution 2758, adopted by the UN General Assembly in 1971, recognizes the People’s Republic of China (PRC) as the “only lawful representative of China.” It resulted in the Republic of China (ROC) losing its seat at the UN to the PRC. Taiwan has since been excluded from